Table 2 Overview of subgroups of microvascular complications in 222 patients
No microvascular complications (n = 111) | 1 microvascular complication (n = 75) | 2–3 microvascular complications (n = 36) | |
|---|---|---|---|
Albuminuria* | |||
No albuminuria | 111 (100) | 47 (63) | 12 (33) |
Microalbuminuria | 0 (0) | 25 (33) | 23 (64) |
Macroalbuminuria | 0 (0) | 3 (4) | 1 (3) |
Nephropathy | |||
No CKD | 7 (6) | 2 (3) | 3 (8) |
Mild CKD | 96 (86) | 65 (87) | 29 (81) |
Moderate CKD (stage IIIa) | 8 (7) | 8 (11) | 4 (11) |
Diabetic retinopathy* | |||
No retinopathy | 104 (94) | 45 (60) | 4 (11) |
Mild NPDR | 0 (0) | 15 (20) | 11 (30.5) |
Moderate NPDR | 0 (0) | 8 (11) | 11 (30.5) |
Severe NPDR | 0 (0) | 2 (3) | 5 (14) |
PDR | 0 (0) | 4 (5) | 5 (14) |
Peripheral neuropathy* | |||
Normal sensitivity | 87 (78) | 48 (64) | 9 (25) |
Reduced sensitivity | 0 (0) | 17 (23) | 24 (67) |
No sensitivity | 0 (0) | 1 (1) | 3 (8) |